AudioScholar Rheumatology Weekly

AudioScholar
  • 0.0 (0)
  • Medicine
  • Updated Weekly

Rheumatology — a weekly podcast briefing of the most significant peer-reviewed rheumatology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

  1. 3d ago

    This Week in Rheumatology — Aug 28, 2026

    Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning lupus — from rare-manifestation consensus to cognition and epidemiology — drug safety and cardiovascular risk in gout and vasculitis, and biomarkers and imaging… This week's papers: 1. ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2). — Lancet Rheumatology 2026 2. Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled c… — Annals of the Rheumatic Diseases 2026 3. Time-varying cardiovascular risk of febuxostat versus allopurinol in gout: a one-stage meta-analysis. — Rheumatology 2026 4. Hepatotoxicity of Avacopan: Real-World Incidence and Confirmed Cases of Severe Drug-Induced Liver Injury in a US National Rheumatology Registry. — Arthritis & Rheumatology 2026 5. Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years. — Annals of the Rheumatic Diseases 2026 6. Age-specific Incidence of Systemic Lupus Erythematosus in the United States: A Meta-Analysis of Data from the Centers for Disease Control and Prevention Lupus… — Arthritis & Rheumatology 2026 7. Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody-defined subgroups. — Rheumatology 2026 8. The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review. — Rheumatology 2026 9. Acute parvovirus B19-associated inflammatory musculoskeletal disease: clinical phenotypes and remission trajectories from the GIRRCS Network. — Rheumatology 2026 10. Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis. — Rheumatology 2026 Listen at https://audioscholar.cc/episode/xaumah8j28

  2. Aug 21

    This Week in Rheumatology — Aug 21, 2026

    Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning treatment strategy and drug delivery in rheumatoid arthritis, the lung as a shared target across connective tissue disease, and how classification criteria, imm… This week's papers: 1. Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management-a multic… — RMD Open 2026 2. Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial — Rheumatology 2026 3. Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis — Rheumatology 2026 4. Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis — Rheumatology 2026 5. Cost-effectiveness of herpes zoster vaccination in patients with rheumatoid arthritis — Rheumatology 2026 6. Prevalence and clinical relevance of anti-drug antibodies in psoriatic arthritis: a systematic review — RMD Open 2026 7. Prevalence and incidence of interstitial lung diseases in systemic lupus erythematosus: systematic review and meta-analyses — Lupus Science & Medicine 2026 8. Canakinumab dosing intervals in pediatric colchicine-resistant FMF: outcomes and predictors of successful extension in a real-world cohort — Rheumatology 2026 9. Clinical characteristics and outcomes of paediatric CNO: a retrospective cohort study with focus on zoledronic acid — Rheumatology 2026 10. Different age, different phenotype: a comparative analysis of juvenile and adult-onset dermatomyositis from a tertiary center — Rheumatology 2026 Listen at https://audioscholar.cc/episode/k9uscyc6yt

  3. Aug 13

    This Week in Rheumatology — Aug 13, 2026

    Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning targeted synthetic and biologic therapy across spondyloarthritis, psoriasis and myositis; treat-to-target and prognostic thinking in lupus, lupus nephritis and… This week's papers: 1. Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial con… — Annals of the Rheumatic Diseases 2027 2. Biologic DMARD class influences progression from psoriasis to PsA: A real-world cohort study — Rheumatology 2026 3. Long-term effectiveness of the Early Arthritis Recognition Clinic's screening for the presence of clinical arthritis in the Netherlands: a single-centre, longi… — Lancet Rheumatology 2026 4. Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline — Seminars in Arthritis and Rheumatism 2026 5. Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve — Rheumatology 2026 6. Effectiveness and safety of rituximab-pvvr versus originator rituximab for rheumatoid arthritis in the veterans health administration — Rheumatology 2026 7. Attainment of early targets does not ensure a complete response at 12 months in lupus nephritis, especially in nephrotic-range proteinuria — Rheumatology 2026 8. Effectiveness and safety of upadacitinib on adult dermatomyositis: a cohort study in China — Seminars in Arthritis and Rheumatism 2026 9. Early haematologic response to anifrolumab in systemic lupus erythematosus: results from the european multicentre EFFORT-SLE study — Rheumatology 2026 10. Treatment strategies for relapsing IgG4-RD: twelve-year experience from a prospective cohort — Rheumatology 2026 Listen at https://audioscholar.cc/episode/9fsqa626h5

  4. Aug 6

    This Week in Rheumatology — Aug 6, 2026

    Welcome to This Week in Rheumatology. This week we're covering 8 notable papers spanning treatment optimisation in rheumatoid arthritis, connective tissue disease lung involvement and guideline navigation, and two very different attempts to move the… This week's papers: 1. Navigating evidence-based recommendations for the management of systemic sclerosis — Nature Reviews Rheumatology 2026 2. Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials — The Lancet Rheumatology 2026 3. Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica — RMD Open 2026 4. Therapeutic approaches for difficult-to-treat rheumatoid arthritis: a systematic literature review of current evidence — RMD Open 2026 5. Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real-world data from the ILD-PRO Registry — Arthritis & Rheumatology 2026 6. Advances in the treatment of eosinophilic granulomatosis with polyangiitis — Nature Reviews Rheumatology 2026 7. Low Dose Radiation Therapy and Osteoarthritis Pain — Arthritis & Rheumatology 2026 8. Safety, biodistribution, and exploratory clinical outcomes of a novel intra-articular IL-1Ra gene therapy (PCRX-201) in moderate-to-severe knee osteoarthritis:… — Annals of the Rheumatic Diseases 2026 Listen at https://audioscholar.cc/episode/uunvnra36h

  5. Jul 31

    This Week in Rheumatology — Jul 31, 2026

    Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning critical advances in systemic lupus erythematosus, prognostic biomarkers in systemic sclerosis, and evolving therapeutic strategies in inflammatory arthritis, v… This week's papers: 1. Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years. — Annals of the rheumatic diseases 2026 2. Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study. — RMD open 2026 3. Redefining the Landscape: Acquired Mutations Driving Systemic Autoinflammatory Diseases. — Arthritis & rheumatology (Hoboken, N.J.) 2026 4. Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial. — Annals of the rheumatic diseases 2026 5. Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus. — RMD open 2026 6. Prolonged serologically active clinically quiescent systemic lupus erythematosus: a longitudinal study on the role of IgG anti-dsDNA and C3. — Rheumatology (Oxford, England) 2026 7. Anti-carbamylated fibrinogen autoantibodies of IgG and IgA isotypes contribute to a better prognostic stratification in very early rheumatoid arthritis: data f… — Arthritis & rheumatology (Hoboken, N.J.) 2026 8. Risk of falls, recurrent falls and osteoporotic fractures in SLE patients with comorbid fibromyalgia: a propensity score-matched cohort study using the TriNetX… — Lupus science & medicine 2026 9. Anakinra for intravenous immunoglobulin-resistant Kawasaki disease: a systematic literature review. — RMD open 2026 10. High levels of Vascular Cell Adhesion Molecule 1 associate with a 'vasculopathic' phenotype in systemic sclerosis with higher mortality. — Rheumatology (Oxford, England) 2026 Listen at https://audioscholar.cc/episode/gzx7dy787b

  6. Jul 23

    This Week in Rheumatology — Jul 23, 2026

    Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning vasculitis management, spondyloarthritis therapeutics, rare autoimmune conditions, and early rheumatoid arthritis detection. Let's dive in. Beginning with vasc… This week's papers: 1. 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis. — Annals of the rheumatic diseases 2026 2. Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial. — Arthritis & rheumatology (Hoboken, N.J.) 2026 3. A phase 2 trial of rilzabrutinib in IgG4-related disease. — Annals of the rheumatic diseases 2026 4. Effects of first-line biologic immunomodulation compared with non-biologic therapies in adult-onset Still's disease: a two-center cohort study. — Arthritis research & therapy 2026 5. Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal… — Annals of the rheumatic diseases 2026 6. Lung disease in adult-onset Still's disease: a chinese cohort study. — Rheumatology (Oxford, England) 2026 7. The WORKWELL programme: a randomised controlled trial of job retention vocational rehabilitation for people with inflammatory arthritis. — Rheumatology (Oxford, England) 2026 8. Single-cell analysis identifies monocyte signatures of disease activity and clinical subtypes in Behçet's disease. — Annals of the rheumatic diseases 2026 9. Nutritional interventions and dietary supplements in muscle diseases: a systematic review. — Rheumatology (Oxford, England) 2026 10. Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase. — Rheumatology (Oxford, England) 2026 Listen at https://audioscholar.cc/episode/jfryuwt9xp

  7. Jul 16

    This Week in Rheumatology — Jul 16, 2026

    Welcome to This Week in Rheumatology. This week we are covering ten notable papers spanning three broad themes: novel therapeutic pathways and real-world outcomes in vasculitis and autoinflammatory diseases, optimized screening and patient-reported m… This week's papers: 1. Zanubrutinib monotherapy for IgG4-related head and neck disease. — Annals of the Rheumatic Diseases 2026 2. Real-world efficacy and safety of avacopan in ANCA-associated vasculitis: a retrospective comparative study. — RMD Open 2026 3. Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research c… — RMD Open 2026 4. Risk of cancer induced by human papillomavirus in patients with immune-mediated inflammatory diseases: a nationwide matched cohort study. — RMD Open 2026 5. Fibromyalgia. — The New England Journal of Medicine 2026 6. Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 year… — Annals of the Rheumatic Diseases 2026 7. International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study. — Lupus Science & Medicine 2026 8. Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network. — Rheumatology (Oxford, England) 2026 9. Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung disease. — RMD Open 2026 10. Time to diagnosis in large vessel vasculitis: insights from a retrospective study at a tertiary rheumatology centre. — RMD Open 2026 Listen at https://audioscholar.cc/episode/db6b8w9s3p

  8. Jul 9

    This Week in Rheumatology — Jul 9, 2026

    Welcome to This Week in Rheumatology. This week we are covering eight notable papers spanning advances in spondyloarthritis diagnosis and tracking, the genetic and therapeutic landscapes of giant cell arteritis, and emerging tools to predict complica… This week's papers: 1. Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project — Annals of the Rheumatic Diseases 2026 2. A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus — Annals of the Rheumatic Diseases 2026 3. Enhancing diagnostic accuracy in axial spondyloarthritis through centralised clinical and imaging evaluation: results from a prospective multicentre project — Annals of the Rheumatic Diseases 2026 4. Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French he… — RMD Open 2026 5. Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and mat… — RMD Open 2026 6. Pediatric macrophage activation syndrome: clinical features and outcomes across diverse etiologies — Rheumatology (Oxford) 2026 7. Development and assessment of an assisted diagnosis model using machine learning for identifying adult-onset Still's disease in fever of unknown origin: a retr… — RMD Open 2026 8. Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups — Annals of the Rheumatic Diseases 2026 Listen at https://audioscholar.cc/episode/zx7qcukmca

See All (16)

About

Rheumatology — a weekly podcast briefing of the most significant peer-reviewed rheumatology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Information